Zai Lab Ltd (ZLAB)
17.78
-0.41
(-2.25%)
USD |
NASDAQ |
May 31, 16:00
17.79
+0.01
(+0.06%)
After-Hours: 20:00
Zai Lab SG&A Expense (Annual): 281.61M for Dec. 31, 2023
SG&A Expense (Annual) Chart
Historical SG&A Expense (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 281.61M |
| December 31, 2022 | 258.97M |
| December 31, 2021 | 218.83M |
| December 31, 2020 | 111.31M |
| December 31, 2019 | 70.21M |
| Date | Value |
|---|---|
| December 31, 2018 | 21.58M |
| December 31, 2017 | 12.05M |
| December 31, 2016 | 6.380M |
| December 31, 2015 | 2.762M |
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (Annual) Range, Past 5 Years
70.21M
Minimum
2019
281.61M
Maximum
2023
188.19M
Average
218.83M
Median
2021
SG&A Expense (Annual) Benchmarks
| Dr Reddy's Laboratories Ltd | 1.434B |
| Concord Medical Services Holdings Ltd | 54.62M |
| ASLAN Pharmaceuticals Ltd | 13.24M |
| Sinovac Biotech Ltd | 466.32M |
| CASI Pharmaceuticals Inc | 41.84M |